Cover Image

PAPERBACK
$111.75



View/Hide Left Panel

Inada S, Hiragun K, Seo K, Yamura T. 1978. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan with special reference to mustard gas exposure. Journal of Dermatology 5:49-60.


Jones RN, Weill H, Ziskind M. 1975. Pulmonary function in sandblasters' silicosis. Bulletin de Physio-Pathologie Respiratoire 11:589-595.

Jones RN, Hughes JM, Glindmeyer H, Weill H. 1986. Lung function after acute chlorine exposure. American Review of Respiratory Disease 134:1190-1195.


Keshmiri M. 1989. Pulmonary cause of death from chemical warfare agents: the Halabche experience. Iranian Journal of Medical Sciences 14:10-19.


Lippman M, ed. 1992. Environmental Toxicants, Human Exposures and Their Health Effects. New York: Van Nostrand Reinhold.


Manning KP, Skegg DCG, Stell PM, Doll R. 1981. Cancer of the larynx and other occupational hazards of mustard gas workers. Clinical Otolaryngology and Allied Sciences 6:165-170.

Martin CVF, Higgins JE. 1976. Byssinosis and other respiratory ailments. Journal of Occupational Medicine 16:455-462.

Menzel DB, Amdur MO. 1986. Toxicology responses of the respiratory system. In: Klaassen CD, Amdur MO, Doull J, eds. Casarett and Doull's Toxicology. 3rd ed. New York: Macmillan.

Morgenstern P, Koss FR, Alexander WW. 1947. Residual mustard gas bronchitis: effects of prolonged exposure to low concentrations of mustard gas. Annals of Internal Medicine 26:27-40.

Muggia FM. 1983. Pulmonary toxicity of anti-tumor agents. Cancer Treatment Reviews 10:221-243.


National Research Council. 1979. Airborne Particles. Baltimore: University Park Press.

Nishimoto Y, Burrows B, Miyanishi M, Katsuta S, Shigenobu T, Kettel LJ. 1970. Chronic obstructive lung disease in Japanese poison gas workers. American Review of Respiratory Disease 102:173-179.


Office of Scientific Research and Development. National Defense Research Committee. 1946. Summary Technical Report of Division 9, NDRC. Chemical Warfare Agents and Related Chemical Problems. Parts I-VI. Washington, DC: NDRC. AD-234 249.


Papirmeister B, Feister AJ, Robinson SI, Ford RD. 1991. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. Boca Raton, FL: CRC Press.

Peters JM, Wegman DH. 1975. Epidemiology of toluene diisocyanate (TDI) induced respiratory disease. Environmental Health Perspectives 11:97-100.

Peters JM, Murphy RLH, Pagnotto LD, Van Ganse WF. 1968. Acute respiratory effects in workers exposed to low levels of toluene diisocyanate (TDI). Archives of Environmental Health 16:642-647.

Phalen RF, Prasad SB. 1988. Morphology of the respiratory tract. In: McClellan RO, Henderson RF, eds. Concepts in Inhalation Toxicology. New York: Hemisphere.

Project Coordination Staff, Chemical Warfare Service. 1946. Technical Aspects of Chemical Warfare in the Field. 2 vols. Washington, DC: Chemical Warfare Service.


Robinson JP. 1967. Chemical warfare. Science Journal 4:33-40.

Rodriques-Roisin R, Picado C, Roca J, Arrigo S, Agusti-Vidal A. 1986. Early lung function changes after short heavy exposure to chrysotile asbestos in non-smoking women. Bulletin Europeen de Physiopathologie Respiratoire 22:225-229.

Rosenow EC, Wilson WR, Cockerill FR. 1985. Pulmonary disease in the immunocompromised host . Mayo Clinic Proceedings 60:473-487.


Sandall TE. 1922. The later effects of gas poisoning. Lancet 2:857-859.

Sidell FR. 1990. Clinical Notes on Chemical Casualty Care. USAMRICD Technical Memorandum 90-1. Aberdeen Proving Ground, MD: U.S. Army Medical Research Institute of Chemical Defense.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement